George Kontoghiorghes

This inventor holds 15 USPTO granted patents, primarily in Pharmaceutical Compositions. Top assignees: National Research Development Corporation, National Research Corporation. Active years: 1985-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George Kontoghiorghes. Retrieved from https://idiyas.com/inventor/george-kontoghiorghes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 10

Forward Citations = 240(Granted Patents)

Company Filing History:

14 out of 1,200

National Research Development Corporation

patents

1 out of 1

National Research Corporation

patent

Years Active: 1985-1993

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

Iron Complexes

Hydroxypyridones

Zinc Complexes

Iron Overload

Anemia Treatment

3-Hydroxypyrid-2-Ones

3-Hydroxyprid-4-Ones

Zinc Levels

Iron Deficiency

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5177068 - Pharmaceutical compositions (1993-01-05),

2. 5104865 - Iron complexes of hydroxypyridones useful for treating iron overload (1992-04-14),

3. 5028411 - Pharmaceutical compositions (1991-07-02),

4. 4912118 - Pharmaceutical compositions (1990-03-27),

5. 4894455 - Pharmaceutically active zinc complexes (1990-01-16),

6. 4861767 - Pharmaceutical compositions (1989-08-29),

7. 4840958 - Novel 3-hydroxypyrid-2-ones and 3-hydroxyprid-4-ones useful in treating (1989-06-20),

8. 4834983 - Pharmaceutical compositions (1989-05-30),

9. 4666927 - Pharmaceutical compositions of hydroxypyridones (1987-05-19),

10. 4665064 - Pharmaceutical compositions and methods for increasing zinc levels (1987-05-12),

11. 4650793 - Iron-pyridone complexes for anemia (1987-03-17),

12. 4587240 - Pharmaceutical compositions (1986-05-06),

13. 4585780 - Pharmaceutical compositions (1986-04-29),

14. 4575502 - Pharmaceutical compositions (1986-03-11),

15. 4550101 - Iron complexes of hydroxy pyridones useful for treating iron deficiency (1985-10-29),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I will create an article based on the provided data about inventor George Kontoghiorghes.

Title: Unveiling the Innovations of George Kontoghiorghes in London

Introduction:

George Kontoghiorghes is a prolific inventor based in London, UK, renowned for his groundbreaking contributions to the field of pharmaceutical compositions. With a remarkable portfolio of 15 patents, he has significantly impacted the medical and scientific communities with his novel discoveries and inventions.

Latest Patents:

Kontoghiorghes' latest patents showcase his expertise in developing pharmaceutical compositions focused on iron complexes comprising a ferric cation in combination with unique ligands. These compositions, particularly iron complexes of hydroxypyridones, have shown promise in treating iron overload and iron deficiency anaemia.

Career Highlights:

Having worked with esteemed organizations such as the National Research Development Corporation and National Research Corporation, Kontoghiorghes has honed his skills and expertise in the research and development sector. His innovative approach to pharmaceutical compositions has earned him recognition as a pioneer in the field.

Collaborations:

Throughout his career, George Kontoghiorghes has collaborated with notable individuals in the industry, including Robert Charles Hider and Michael A Stockham. These partnerships have fostered a culture of innovation and knowledge-sharing, leading to the successful development of groundbreaking inventions.

Conclusion:

In conclusion, George Kontoghiorghes stands as a visionary inventor whose dedication to scientific advancement has revolutionized the field of pharmaceutical compositions. His remarkable patents and collaborations underscore his significant contributions to the scientific community, positioning him as a leading figure in the realm of medical innovation.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]